MEVALONATE KINASE DEFICIENCY

This adverse event was reported 9 times

These drugs are most commonly taken by patients reporting MEVALONATE KINASE DEFICIENCY:

# Drug Count
0 CANAKINUMAB 8
1 ADALIMUMAB 1
2 ADALIMUMAB-AATY 1
3 ADALIMUMAB-ADAZ 1
4 ADALIMUMAB-FKJP 1
5 ANAKINRA 1
6 COLCHICINE 1
7 FOLIC ACID 1
8 METHYLPREDNISOLONE 1
9 SULFASALAZINE 1
See all common drugs associated with MEVALONATE KINASE DEFICIENCY

MEVALONATE KINASE DEFICIENCY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CANAKINUMAB 8 0.0007
1 ANAKINRA 1 0.0001
2 COLCHICINE 1 0.0000
3 ADALIMUMAB-FKJP 1 0.0000
4 ADALIMUMAB-AATY 1 0.0000
5 ADALIMUMAB-ADAZ 1 0.0000
6 SULFASALAZINE 1 0.0000
7 METHYLPREDNISOLONE 1 0.0000
8 FOLIC ACID 1 0.0000
9 ADALIMUMAB 1 0.0000
See all drugs enriched for association with MEVALONATE KINASE DEFICIENCY

MEVALONATE KINASE DEFICIENCY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-1 Receptor Antagonist [EPC] 1 0.0001
1 Alkaloid [EPC] 1 0.0000
2 Aminosalicylate [EPC] 1 0.0000
3 Vitamin D [EPC] 1 0.0000
4 Vitamin B12 [EPC] 1 0.0000
5 Vitamin C [EPC] 1 0.0000
6 Tumor Necrosis Factor Blocker [EPC] 1 0.0000
7 Corticosteroid [EPC] 1 0.0000
See all drug classes enriched for association with MEVALONATE KINASE DEFICIENCY